ACTIVE MOTIF, INC.

Active Motif, Inc. specializes in advanced epigenomic and genomic analysis services, delivering cutting-edge research tools and laboratory execution for life science applications. The company provides high-complexity sequencing services including ATAC-seq, RNA-seq, and ChIP-seq, with deep expertise in chromatin profiling, histone modification analysis, and gene expression characterization. Their technical capabilities extend to the development and supply of specialized reagents for epigenetic assays, particularly those targeting histone marks such as H3K27ac, and the manufacturing of in-vitro diagnostic substances used in molecular biology workflows. Active Motif distinguishes itself through its integrated approach—combining assay design, reagent production, and analytical services under one roof—enabling end-to-end support for complex epigenomic research projects in academic and government settings. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, consistently supporting research initiatives in genomics, epigenetics, and translational biology. Additional engagements with the Department of Veterans Affairs and the Department of Agriculture reflect a focus on biomedical and agricultural life sciences research, particularly in immune cell profiling and chromatin dynamics in non-human models. Active Motif operates primarily under NAICS codes 541714 and 541715, underscoring its role in life sciences R&D, with supplementary work in medical laboratories and in-vitro diagnostic manufacturing. The company is positioned as a niche provider of epigenetic analysis platforms, serving government-funded research programs that require precision molecular characterization beyond standard sequencing services. Active Motif, Inc. is a small business entity headquartered in Carlsbad, California, with no federal certifications on record. Its geographic presence is centered in Southern California’s biotech corridor, aligning it with major research institutions and federal science agencies seeking specialized genomic and epigenetic expertise.